Show simple item record

Authordc.contributor.authorAbello Cáceres, Paula 
Authordc.contributor.authorPizarro Bauerle, Javier 
Authordc.contributor.authorRosas Chuñil, Carlos Alberto 
Authordc.contributor.authorMaldonado, Ismael 
Authordc.contributor.authorAguilar Guzmán, Lorena Andrea 
Authordc.contributor.authorGonzález Guevara, Carlos Mauricio 
Authordc.contributor.authorRamírez Toloza, Galia Andrea 
Authordc.contributor.authorFerreira Parker, Jorge 
Authordc.contributor.authorFerreira Vigouroux, Luis Arturo 
Admission datedc.date.accessioned2017-03-01T19:35:04Z
Available datedc.date.available2017-03-01T19:35:04Z
Publication datedc.date.issued2016
Cita de ítemdc.identifier.citationBMC Cáncer. Volumen: 16 Número de artículo: 731es_ES
Identifierdc.identifier.issn1471-2407
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/142849
Abstractdc.description.abstractBackground: For several decades now an antagonism between Trypanosoma cruzi infection and tumor development has been detected. The molecular basis of this phenomenon remained basically unknown until our proposal that T. cruzi Calreticulin (TcCRT), an endoplasmic reticulum-resident chaperone, translocated-externalized by the parasite, may mediate at least an important part of this effect. Thus, recombinant TcCRT (rTcCRT) has important in vivo antiangiogenic and antitumor activities. However, the relevant question whether the in vivo antitumor effect of T. cruzi infection is indeed mediated by the native chaperone (nTcCRT), remains open. Herein, by using specific modified anti-rTcCRT antibodies (Abs), we have neutralized the antitumor activity of T. cruzi infection and extracts thereof, thus identifying nTcCRT as a valid mediator of this effect. Methods: Polyclonal anti-rTcCRT F(ab')(2) Ab fragments were used to reverse the capacity of rTcCRT to inhibit EAhy926 endothelial cell (EC) proliferation, as detected by BrdU uptake. Using these F(ab')(2) fragments, we also challenged the capacity of nTcCRT, during T. cruzi infection, to inhibit the growth of an aggressive mammary adenocarcinoma cell line (TA3-MTXR) in mice. Moreover, we determined the capacity of anti-rTcCRT Abs to reverse the antitumor effect of an epimastigote extract (EE). Finally, the effects of these treatments on tumor histology were evaluated. Results: The rTcCRT capacity to inhibit ECs proliferation was reversed by anti-rTcCRT F(ab')(2) Ab fragments, thus defining them as valid probes to interfere in vivo with this important TcCRT function. Consequently, during infection, these Ab fragments also reversed the in vivo experimental mammary tumor growth. Moreover, anti-rTcCRT Abs also neutralized the antitumor effect of an EE, again identifying the chaperone protein as an important mediator of this anti mammary tumor effect. Finally, as determined by conventional histological parameters, in infected animals and in those treated with EE, less invasive tumors were observed while, as expected, treatment with F(ab')(2) Ab fragments increased malignancy. Conclusion: We have identified translocated/externalized nTcCRT as responsible for at least an important part of the anti mammary tumor effect of the chaperone observed during experimental infections with T. cruzi.es_ES
Lenguagedc.language.isoenes_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceBMC Cánceres_ES
Keywordsdc.subjectAngiogenesises_ES
Keywordsdc.subjectCalreticulines_ES
Keywordsdc.subjectTrypanosoma cruzies_ES
Keywordsdc.subjectMammary tumores_ES
Títulodc.titleDoes native Trypanosoma cruzi calreticulin mediate growth inhibition of a mammary tumor during infection?es_ES
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorC. R. B.es_ES
Indexationuchile.indexArtículo de publicación ISIes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile